Back to search

Article

The Metabolic Bone Disease X-Linked Hypophosphatemia: Case Presentation, Pathophysiology and Pharmacology

2021-05-10

Abstract excerpt

The authors present a stereotypical case presentation of x-linked hypophosphatemia (XLH) and provide a review of the pathophysiology and related pharmacology of this condition, primarily focusing on the FDA-approved medication burosumab. XLH is a renal phosphate wasting disorder caused by loss of function mutations in the PHEX gene (phosphate-regulating gene with homologies to endopeptidases on the X chromosome)....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b09c8f7c-ce78-5f63-b224-522af1ebe013
DOI
10.20944/preprints202105.0202.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Metabolic Bone Disease X-Linked Hypophosphatemia: Case Presentation, Pathophysiology and PharmacologyDOI 10.20944/preprints202105.0202.v1
Select a neighboring publication to make it the new centre.